VPT.V · VentriPoint Diagnostics Ltd

-

Please sign in to comment on VPT.V

1 Comment

Admin

4 years, 1 month ago

VentriPoint Diagnostics Ltd is currently in a long term uptrend where the price is trading 15.3% above its 200 day moving average.

From a valuation standpoint, the stock is 12.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 888.9.

VentriPoint Diagnostics Ltd's total revenue rose by inf% to $6K since the same quarter in the previous year.

Its net income has dropped by 12.0% to $-608K since the same quarter in the previous year.

Finally, its free cash flow fell by 54.3% to $-197K since the same quarter in the previous year.

Based on the above factors, VentriPoint Diagnostics Ltd gets an overall score of 3/5.

Sector	Healthcare
Industry	Medical Devices
Exchange	V
CurrencyCode	CAD
ISIN	CA92281P2008

Market Cap	22M
PE Ratio	None
Target Price	None
Beta	0.15
Dividend Yield	None

ABOUT

VentriPoint Diagnostics Ltd

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. The company also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.

VPT.V · VentriPoint Diagnostics Ltd

-

VentriPoint Diagnostics Ltd

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest VentriPoint Diagnostics Ltd using a moving average strategy